Expression pattern of the ap-1 family in breast cancer: Association of fosb expression with a well-differentiated, receptor-positive tumor phenotype

International Journal of Cancer

Volumn 84, Issue 5, 1999, Pages 533-538

  Bamberger, Ana Maria ^a   Methner, Carola ^a   Lisboa, Björn W ^a   Städtler, Garsten ^a   Schulte, Heinrich M ^a   Löning, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN C FOS; PROTEIN C JUN;

ARTICLE; BREAST TUMOR; CELL CULTURE; CHEMISTRY; FEMALE; HUMAN; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PATHOLOGY; PHENOTYPE; PHOSPHORYLATION;

BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PHENOTYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR CELLS, CULTURED;

EID: 0033595634     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991022)84:5<533::AID-IJC16>3.0.CO;2-J     Document Type: Article

References (24)

1. ANGEL, P., IMAGAWA, M., CHIU, R., STEIN, B., IMBRA, R.J., RAHMSDORF, HJ., JO.NAT, C., HERRLICH, P. and KARIN, M., Phorbol-ester-inducible genes contain a common cis element recognized by a TPA-modulated transacting factor. Cell, 49, 729-739 (1987).
2. ANGEL, P. and KARIN, M., The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochim. biophys. Ada, 1072, 129-157 (1991).
3. BERGERS, G., GRANINGER, P., BRASELMANN, S., WRIGHTON, C. and BusSLINGER, M., Transcriptional activation of the /ra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Dial., 15, 3748-3758 (1995).
4. BLAND, K.I., KONSTADOULAKIS, M.M., VEZERIDIS, M.P. and WANEBO, H.J., Oncogene protein co-expression. Value of Ha-raj, c-myc, c-fos and p53 as prognostic discriminants for breast carcinoma. Ann. Surg., 221, 706-720 (1995).
5. BROWN, J.R., YE, H., BRONSON, R.T., DIKKES, P. and GREENBERG, M.E., A defect in nurturing in mice lacking the immediate early gene/osB. Cell, 86, 297-309(1996).
6. CHEN, T.K., SMITH, L.M., GEBHARDT, O.K., BIRRER, M.J. and BROWN, P.H., Activation and inhibition of the AP-1 complex in human breast-cancer cells. Mol. Carcinog., 15, 215-226(1996).
7. CIOCCA, D.R. and FANELLI, M.A., Estrogen receptors and cell proliferation in breast cancer. Trends Endocrinol. Metab., 8, 313-321 (1997).
8. FEUER, E.J., WUN, L.M. and BORING, C.C., The lifetime risk of developinc breast cancer. J. not. Cancer Insl., 85, 892-897 (1993).
9. GRUDA, M.C., KOVARY, K., METZ, R. and BRAVO, R., Regulation of fra-1 and fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation m vitro by MAP kinase affects DNA-binding activity. Oncogene, 9, 2537-2547 (1994).
10. KARIN, M., Ltu, Z.-G. and ZANDJ, E., AP-1 function and regulation. Curr. Opin. Cell Biol., 9, 240-246 (1997).
11. KUSTIKOVA, O., KRAMEROV, D., GRIGORIAN, M., BEREZIN, V., BOCK, E., LUKANIDLM, E. and TULCHINSKY, E., fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelial adenocarcinoma cells. Mot. cell. Biol., 18, 7095-7105 (1998).
12. LAZO, P.S., DORFMAN, K., NOGUCHI, T., MATTEI, M.-G. and BRAVO, R., Structure and mapping of the/osB gene. fosB down-regulates the activity of the fosB promoter. Nucleic Acids Res., 20, 343-350 (1992).
13. LEE, W., MiTCHELL, P. and TJIAN, R., Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 49, 741-752 (1987).
14. LUCIBELLO, EC., SLATER, E.P., Jooss, K.U., BEATO, M. and MÜLLER, R., Mutual transrepression of fos and the glucocorticoid receptor: involvement of a functional domain in fos which is absent in fosB. EMBO J., 9, 2827-2834(1990).
15. MILLER, D.A., CURRAN, T. and VERMA, I.M., c-fos protein can induce cellular transformation: a novel mechanism of a cellular oncogene. Cell, 36, 51-60(1984).
16. PFAHL, M., Nuclear receptor/AP-1 interaction. Endocr. Rev., 14, 651-658 (1993).
17. PHILIPS, A., TEYSSIER, C., GALTIER, R, RiviER-CovAs, C., REY, J.M., ROCHEFORT, H. and CIIALBOS, D., fra-1-expression level modulates regulation of activator-protein-1 activity by estradiol in breast-cancer cells. Mol. Endocrinol., 12, 973-985 (1998).
18. RANSONE, L.J. and VERMA, I.M., Nuclear proto-oncogenes/os andjun. Ann. Rev. Cell Biol, 6, 539-557 (1990).
19. ROSEN, J.M., ZAIINOW, C., KAZANSKY, A. and RAUCHT, B., Composite response elements mediate hormonal and developmental regulation of milk protein gene expression. Biocliem. Soc. Synip., 63, 101-113(1998).
20. RYSECK, R.-P. and BRAVO, R., c-jun, jun B andjun D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of fos proteins. Oncogene, 6, 533-542 (1991).
21. SCHUTTE, J., MINNA, J.D. and BIRRER, M.J., De-regulated expression of human c-jun transforms primary rat embryo fibroblasts in cooperation with an activated c-Ha-ras gene and transforms Rat-la cells as a single gene. Proc. not. Acad. Sei. (Wash.), 86, 2257-2261 (1989).
22. SUZUKI, T., OKUNO, H., YOSIIIDA, T., ENDO, T., NISHINA, H. and IBA, H., Difference in transcriptional regulatory function between c-fos and fra-2. Nucleic Acids Res., 19, 5537-5542 (1991).
23. TANG, Z., TREILLEUX, I. and BROWN, M., A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers. Mol. cell. Biol., 17, 1274-1280 (1997).
24. WELTER, J.F. and ECKERT, R.L., Differential expression of the fos and jun family members c-fos, fosB, fra-1, fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation. Oncogene, 11, 2681-2687 (1995).